Evidence map›Paper›PMID 33377321›Full record

ArticleInfection & chemotherapy2020

The Outcome of Fungal Pneumonia with Hematological Cancer.

Esma Eren, Emine Alp, Fatma Cevahir, Tuğba Tok, Ayşegül Ulu Kılıç, Leylagül Kaynar, Recep Civan Yüksel

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection & chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Esma ErenKayseri City Hospital, Infectious Disease Clinic, Kayseri, Turkey. esmaereneryilmaz@gmail.com.ORCID https://orcid.org/0000-0002-2712-9694
Emine AlpMinistry of Health, Ankara, Turkey.ORCID https://orcid.org/0000-0003-0189-6008
Fatma CevahirUnıversıty of Sakarya Applıed Scıences, Akyazı Vocational School of Health Services, Medical Services and Techniques Department, Sakarya, Turkey.ORCID https://orcid.org/0000-0002-4834-5046
Tuğba TokErciyes University, Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Kayseri, Turkey.ORCID https://orcid.org/0000-0002-9628-8197
Ayşegül Ulu KılıçErciyes University, Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Kayseri, Turkey.ORCID https://orcid.org/0000-0002-4454-374X
Leylagül KaynarErciyes University, Faculty of Medicine, Department of Internal Medicine, Hematology, Kayseri, Turkey.ORCID https://orcid.org/0000-0002-2035-9462
Recep Civan YükselKayseri City Hospital, Intensive Care Unit, Kayseri, Turkey.ORCID https://orcid.org/0000-0003-4496-9473
Erciyes University · TRKayseri Eğitim ve Araştırma Hastanesi · TRMinistry of Health · TRSakarya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFungal pneumonia is a common infectious complication of hematological cancer (HC) patients. In this retrospective study, the objective was set to identify the risk factors and outcome of fungal pneumonia in adult HC patients. MATERIALS AND

methodsThis retrospective study was conducted with adult (>16 years) HC patients from January 2017 and December 2018.

resultsDuring the study period, of 181 patients included 76 were diagnosed with fungal pneumonia. The most common HC was identified as acute myeloid leukaemia (40%). Of the participating patients, 52 (29%) were hematopoietic stem cell transplant (HSCT) recipients. The median age of patients with fungal pneumonia was significantly greater: 57

conclusionFungal pneumonia is a lethal complication in HC patients. Intensive care need is the most important predictive factor for mortality.

Indexed as

Fungal pneumoniaHematological cancerIntensive care

Identifiers

PMID33377321
PMCPMC7779983
OpenAlexW3113690096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.